ENDO 2019 Session Recordings

Keep your endocrine practice up-to-date with ENDO 2019 Session Recordings. This activity provides the latest information available in the field of endocrinology. Taught by expert faculty in a dynamic meeting format, you will finish viewing the ENDO Session Recordings confident that your knowledge has been imporoved from the most current and advanced information possible.  Purchase access to the ENDO 2019 Session Recordings today!

After purchase, click the button below to begin the recordings activity.  You may only claim CME credit for this activity once so be sure to interact with all of the recordings you plan to prior to claiming credit.  

View ENDO2019 Recordings

Go to Endocrine Society Store

Once you are ready, click the Start button to evaluate the ENDO 2019 Recordings for CME credit.

 

 

Learning Objectives

Upon completion of this educational activity, learners will be better able to:

  • Discuss state-of-the-art research in endocrinology
  • Demonstrate updated knowledge of the pathophysiology, diagnosis, and treatment of diabetes, obesity, cardiovascular disease, dyslipidemia, as well as adrenal, metabolic, bone, pediatric, pituitary, thyroid, and reproductive endocrine disorders
  • Employ enhanced skills and practice management techniques to improve patient care

Additional Information

Target Audience: 
Physician-in-practice
Fellow
Resident
Clinical researcher
Scientific researcher
Educator/Teacher
Pharmacist
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Other
Competency Area: 
Medical Knowledge
Topic Area: 
Adrenal/HPA Axis
Bone and Calciotropic Hormones
Diabetes and Glucose Metabolism
Lipid Disorders and Fatty Liver Diseases
Endocrine Disruptors
Quality Improvement and Healthcare Delivery
General Endocrinology
Intercellular Signaling and Gene Regulation
Hormone Abuse
Growth Disorders
Health Disparities
Hormones and Cancer
Men’s Health
Neuroendocrinology and Pituitary
Nuclear Receptors and Steroid Hormones
Nutrition
Obesity
Pediatric Endocrinology
Surgery
Thyroid/HPT Axis
Women’s Health
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Activity summary
Available credit: 
  • 150.00 AMA PRA Category 1 Credits
Course opens: 
04/08/2019
Course expires: 
03/31/2020
Pricing: 
Non-Member
375
Member
250
In Training Member / Early Career Member
200
Rating: 
0

STATEMENT OF INDEPENDENCE

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s Annual Meeting Steering Committee.

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

To view disclosure information for all ENDO presenters, please view the full schedule. Within each session abstract and session description, speaker disclosure is presented.
 

ANNUAL MEETING STEERING COMMITTEE CHAIRS

Susan J. Mandel, MD, MPH, Endocrine Society President
Perelman School of Medicine, University of Pennsylvania

E. Dale Abel, MBBS, MD, PhD, Endocrine Society President-Elect
University of Iowa

Gregory A. Brent, MD, ENDO 2019 Chair
VA Greater LA Healthcare

W. Lee Kraus, PhD, Basic Science Chair
University of Texas Southwestern Medical Center

Ghada El-Hajj Fuleihan, MD, MPH, Clinical Science Chair
American University of Beirut

Susan A. Sherman, MD, Physician-In-Practice Chair
Aurora Medical Associates, PC

Annual Meeting Steering Committee
Cynthia L. Andoniadou, PhD; Sherri-Ann Burnett-Bowie, MD, MPH; Eliot Brinton, MD; Francesco S. Celi, MD; Mark S. Cooper, MD,PHD, FRCP, FRACP; Ann Danoff, MD; Dawn B. Davis, MD,PhD; Scott M. Dehm, PhD; Marie B. Demay, MD; Matthew T. Drake, MD, PhD; Maralyn R. Druce, MD, PhD; Robert Eckel, MD; Ismaa S. Farooqi, PhD, FRCP, FMedSci; Richard A. Feelders, MD,PhD; Lauren M. Fishbein, MD, PhD; Larry A. Fox, MD; Rana K. Gupta, PhD; Aylin C. Hanyaloglu, PhD; Megan R. Haymart, MD; Terence Hebert, Bsc, Msc, PhD; Anders Juul, MD,PhD,DMSC; Bassil Kublaoui, MD; Peter Kopp, MD; Bruce Murphy, PhD, FCAHS; Nicola Napoli, MD, PhD; Kendall W. Nettles, PhD; Nicola C. Partridge, PhD; Margareta D. Pisarska, MD; Sally Radovick, MD; William E. Rainey, II, PhD; Inez Rogatsky, PhD; Darleen Sandoval, PhD; Rebecca E. Schweppe, PhD; Stephanie B. Seminara, MD; Jennifer A. Sipos, MD; Ron T. Varghese, MBBS; Adrian V. Vella, MD, FRCP; Selma F. Witchel, MD; Morag J. Young, PhD

The following AMSC peer reviewers reported relevant financial relationship(s): E. Dale Abel, MBBS, MD, PhD, Advisory Board Member, Novo Nordisk. Eliot Brinton, MD, Advisor and Speaker: Akcea, Amarin, Amgen, Kowa, Merck, Regeneron, Sanofi-Aventis and an Advisor, Balchem, PTS Diagnostics; Speaker, Boehringer-Ingelheim, Novo Nordisk. Francesco S. Celi, MD, MHSc, Advisory Board Member, LioTriDev, IBSA. Dawn B. Davis, MD, PhD, Site PI for clinical trial, Eiger Pharmaceuticals. Scott M. Dehm, PhD, Consultant, Janssen Research and Development LLC, Celgene. Marie B. Demay, MD, (Spouse) CMO - Syros Pharmaceuticals. Maralyn R. Druce, MD, PhD, Advisory Board Member – Specific Consultations, Ipsen. Robert Eckel, MD, Scientific Consultant for Sanofi Aventis, Regeneron Pharmaceuticals and a scientific Advisor for Novo Nordisk, Merck, Amgen. Richard A. Feelders, MD, PhD, Research Grant Recipient, Novartis, Ipsen. Anders Juul, MD, PhD, DMSC, Speakers Bureau, Novo Nordisk, Pfizer, Ferring, Merck, Bayer, Sponsor and PI of a clinical multicenter trial (NESGAS), Department research grant, Ferring, Department funding to participate in the clinical trial (PORIYA), Co-investigator in a Ferring-sponsored clinical trial, Department grantee, Diurnal, and Principal investigator for participation in a multicenter study (RCT) on long-acting hydrocortisone (Chronocort) in CAH. W. Lee Kraus, PhD, Founder, consultant, and stock holder for Ribon Therapeutics, Inc. - a start-up pharma company working in the PARP space.Nicola Napoli, MD, PhD, European Advisory Board Member, UCB, Eli Lilly, Consultant, Amgen, Lilly. Sally Radovick, MD, Consultant regarding GH Treatment, CVS Caremark; retail pharmacy and health care company. William E. Rainey, II, PhD, Scientific Advisory Board Member, Millendo Therapeutics. Darleen Sandoval, PhD, Research Funding, Novo Nordisk, Ethicon, Zafgen Speaker, Novo Nordisk. Stephanie B. Seminara, MD, Scientific Advisory Board Member, Astellas. Jennifer A. Sipos, MD, Advisory Board Consultant and Speaker, Genzyme. Ron T. Varghese, MBBS, Shareholder, Celgene, Mannkind Corp, Merck. Adrian V. Vella, MD, FRCP, Principal Investigator, Novo Nordisk, Investigator, XOMA (multi-center study), Member of Advisory Board, VTV Therapeutics, Bristol Myers Squibb.

The following AMSC peer reviewers reported no relevant financial relationships: Cynthia L. Andoniadou, PhD; Sherri-Ann Burnett-Bowie, MD, MPH; Gregory A. Brent, MD; Mark S. Cooper, MD, PhD; Ann Danoff, MD; Matthew T. Drake, MD, PhD; Ismaa S. Farooqi, PhD, FRCP, FMedSci; Ghada El-Hajj Fuleihan, MD, MPH; Lauren M. Fishbein, MD, PhD; Larry A. Fox, MD; Rana K. Gupta, PhD; Aylin C. Hanyaloglu, PhD; Megan R. Haymart, MD; Terence Hebert, Bsc, Msc, PhD; Peter Kopp, MD; Bassil Kublaoui, MD, PhD; Susan J. Mandel, MD, MPH; Bruce Murphy, PhD, FCAHS; Kendall W. Nettles, PhD; Nicola C. Partridge, PhD; Margareta D. Pisarska, MD; Inez Rogatsky, PhD; Rebecca E. Schweppe, PhD; Susan A. Sherman, MD; Selma F. Witchel, MD; Morag J. Young, PhD.

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.  The Endocrine Society designates this activity for a maximum of 150 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 150.00 AMA PRA Category 1 Credits

Accreditation Period

Course opens: 
04/08/2019
Course expires: 
03/31/2020